Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucocutaneous Lymph Node Syndrome | 43 | 2023 | 536 | 4.580 |
Why?
|
Rheumatology | 14 | 2022 | 615 | 1.650 |
Why?
|
Coronary Aneurysm | 13 | 2023 | 233 | 1.620 |
Why?
|
Immunoglobulins, Intravenous | 20 | 2022 | 668 | 1.350 |
Why?
|
Vasculitis | 7 | 2016 | 522 | 1.220 |
Why?
|
Lyme Disease | 9 | 2021 | 631 | 1.140 |
Why?
|
Immunosuppressive Agents | 13 | 2022 | 4189 | 0.770 |
Why?
|
Dermatomyositis | 5 | 2024 | 258 | 0.750 |
Why?
|
Macrophage Activation Syndrome | 5 | 2023 | 124 | 0.730 |
Why?
|
Evidence-Based Medicine | 12 | 2022 | 3689 | 0.680 |
Why?
|
Glucocorticoids | 8 | 2021 | 2160 | 0.680 |
Why?
|
Antirheumatic Agents | 9 | 2021 | 1366 | 0.660 |
Why?
|
Methylprednisolone | 5 | 2018 | 386 | 0.550 |
Why?
|
Immunologic Factors | 5 | 2015 | 1589 | 0.550 |
Why?
|
Adrenal Cortex Hormones | 3 | 2020 | 1878 | 0.480 |
Why?
|
Child, Preschool | 58 | 2023 | 42217 | 0.460 |
Why?
|
Child | 70 | 2024 | 80134 | 0.440 |
Why?
|
Immunoglobulin A | 1 | 2016 | 978 | 0.420 |
Why?
|
Rheumatic Diseases | 3 | 2016 | 649 | 0.420 |
Why?
|
Decision Support Techniques | 5 | 2021 | 2000 | 0.410 |
Why?
|
Polyarteritis Nodosa | 3 | 2021 | 70 | 0.410 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 269 | 0.400 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 4 | 2021 | 289 | 0.390 |
Why?
|
Mucopolysaccharidoses | 1 | 2011 | 27 | 0.390 |
Why?
|
Collagen Diseases | 1 | 2011 | 39 | 0.390 |
Why?
|
Takayasu Arteritis | 3 | 2021 | 105 | 0.380 |
Why?
|
Cyclophosphamide | 5 | 2021 | 2219 | 0.350 |
Why?
|
Mycophenolic Acid | 1 | 2012 | 350 | 0.350 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2014 | 585 | 0.330 |
Why?
|
Osteomyelitis | 2 | 2012 | 407 | 0.330 |
Why?
|
Arthritis, Infectious | 4 | 2011 | 347 | 0.330 |
Why?
|
Systemic Vasculitis | 1 | 2009 | 37 | 0.330 |
Why?
|
Lupus Nephritis | 1 | 2012 | 317 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 6 | 2014 | 1812 | 0.310 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2021 | 225 | 0.300 |
Why?
|
Hospitalization | 4 | 2016 | 10712 | 0.290 |
Why?
|
Drug Therapy, Combination | 12 | 2021 | 6305 | 0.290 |
Why?
|
Giant Cell Arteritis | 2 | 2021 | 307 | 0.280 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 619 | 0.280 |
Why?
|
Adenosine Deaminase | 2 | 2019 | 250 | 0.270 |
Why?
|
Coronary Vessels | 6 | 2017 | 3111 | 0.270 |
Why?
|
Methotrexate | 5 | 2017 | 1717 | 0.260 |
Why?
|
Autoimmune Diseases | 4 | 2008 | 2243 | 0.250 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 4 | 2016 | 2270 | 0.250 |
Why?
|
Heart Diseases | 2 | 2016 | 2795 | 0.250 |
Why?
|
Infant | 32 | 2021 | 36164 | 0.250 |
Why?
|
Musculoskeletal Diseases | 2 | 2010 | 597 | 0.250 |
Why?
|
Pediatrics | 3 | 2017 | 3589 | 0.240 |
Why?
|
Knee Joint | 2 | 2021 | 1677 | 0.240 |
Why?
|
Adolescent | 39 | 2022 | 88271 | 0.230 |
Why?
|
Neurology | 3 | 2021 | 784 | 0.230 |
Why?
|
Prednisolone | 3 | 2018 | 324 | 0.230 |
Why?
|
Humans | 108 | 2024 | 761098 | 0.230 |
Why?
|
Antibodies, Monoclonal | 5 | 2010 | 9185 | 0.220 |
Why?
|
Chest Pain | 1 | 2010 | 1095 | 0.220 |
Why?
|
Raynaud Disease | 2 | 2006 | 79 | 0.220 |
Why?
|
Immunoglobulin G | 4 | 2014 | 4538 | 0.220 |
Why?
|
Vascular Diseases | 1 | 2011 | 1160 | 0.210 |
Why?
|
Synovial Fluid | 3 | 2021 | 393 | 0.210 |
Why?
|
Software | 1 | 2016 | 4433 | 0.210 |
Why?
|
Anti-Infective Agents | 1 | 2010 | 983 | 0.200 |
Why?
|
Communicable Diseases | 2 | 2021 | 873 | 0.200 |
Why?
|
Leukocytosis | 1 | 2003 | 251 | 0.200 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2019 | 1650 | 0.190 |
Why?
|
Fever | 4 | 2023 | 1618 | 0.180 |
Why?
|
Erythema Chronicum Migrans | 1 | 2020 | 48 | 0.180 |
Why?
|
Arthritis, Psoriatic | 3 | 2008 | 219 | 0.180 |
Why?
|
Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.180 |
Why?
|
Male | 61 | 2022 | 360675 | 0.170 |
Why?
|
Pain Measurement | 4 | 2022 | 3548 | 0.170 |
Why?
|
Female | 62 | 2022 | 392458 | 0.170 |
Why?
|
Interferon Type I | 1 | 2023 | 557 | 0.170 |
Why?
|
Eosinophilia | 2 | 2023 | 557 | 0.170 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2003 | 242 | 0.160 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.160 |
Why?
|
Neutropenia | 1 | 2003 | 885 | 0.150 |
Why?
|
Treatment Outcome | 20 | 2021 | 64670 | 0.150 |
Why?
|
Cell Polarity | 1 | 2021 | 638 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2003 | 709 | 0.150 |
Why?
|
Coronary Thrombosis | 2 | 2016 | 440 | 0.150 |
Why?
|
Amoxicillin | 1 | 1998 | 181 | 0.140 |
Why?
|
Agammaglobulinemia | 1 | 2018 | 171 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2021 | 465 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 3092 | 0.140 |
Why?
|
gamma-Globulins | 2 | 1993 | 119 | 0.130 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 604 | 0.130 |
Why?
|
Medication Therapy Management | 1 | 2017 | 130 | 0.130 |
Why?
|
United States | 17 | 2022 | 72337 | 0.130 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 229 | 0.130 |
Why?
|
Fever of Unknown Origin | 2 | 2009 | 94 | 0.130 |
Why?
|
Penicillins | 1 | 1998 | 403 | 0.120 |
Why?
|
Prednisone | 4 | 2012 | 1565 | 0.120 |
Why?
|
Hearing Loss, Sensorineural | 2 | 1992 | 781 | 0.120 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 12975 | 0.120 |
Why?
|
Remission Induction | 4 | 2021 | 2392 | 0.120 |
Why?
|
Pericardiectomy | 1 | 2014 | 46 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 521 | 0.120 |
Why?
|
Pericardiocentesis | 1 | 2014 | 78 | 0.120 |
Why?
|
Echocardiography | 5 | 2019 | 5006 | 0.110 |
Why?
|
Consensus | 5 | 2021 | 3133 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 913 | 0.110 |
Why?
|
Calcinosis | 1 | 2002 | 1477 | 0.110 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2024 | 2157 | 0.110 |
Why?
|
Retrospective Studies | 18 | 2023 | 80673 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 794 | 0.110 |
Why?
|
Pericarditis | 1 | 2014 | 136 | 0.110 |
Why?
|
Myocarditis | 1 | 2020 | 792 | 0.110 |
Why?
|
Lung Diseases | 1 | 2023 | 1909 | 0.110 |
Why?
|
Pain Perception | 1 | 2014 | 196 | 0.100 |
Why?
|
Pericardial Effusion | 1 | 2014 | 247 | 0.100 |
Why?
|
Blood Sedimentation | 4 | 2019 | 235 | 0.100 |
Why?
|
South America | 1 | 2012 | 179 | 0.100 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2007 | 694 | 0.100 |
Why?
|
North America | 3 | 2021 | 1281 | 0.100 |
Why?
|
Societies, Medical | 2 | 2020 | 3923 | 0.100 |
Why?
|
Steroids | 1 | 2016 | 929 | 0.090 |
Why?
|
Somatoform Disorders | 1 | 2014 | 423 | 0.090 |
Why?
|
Autoantibodies | 4 | 2023 | 2117 | 0.090 |
Why?
|
Hip Joint | 2 | 2011 | 1014 | 0.090 |
Why?
|
Length of Stay | 4 | 2016 | 6420 | 0.090 |
Why?
|
Azathioprine | 1 | 2012 | 354 | 0.090 |
Why?
|
Asia | 1 | 2012 | 621 | 0.090 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7400 | 0.090 |
Why?
|
Pain Threshold | 1 | 2014 | 603 | 0.090 |
Why?
|
Arthralgia | 1 | 2014 | 461 | 0.090 |
Why?
|
Anti-Bacterial Agents | 5 | 2020 | 7405 | 0.090 |
Why?
|
Arthritis | 2 | 2008 | 681 | 0.090 |
Why?
|
Hippocratic Oath | 1 | 2009 | 16 | 0.080 |
Why?
|
Dilatation, Pathologic | 3 | 2010 | 527 | 0.080 |
Why?
|
Proteinuria | 1 | 2012 | 604 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.080 |
Why?
|
Infusions, Intravenous | 3 | 2007 | 2217 | 0.080 |
Why?
|
Myositis | 2 | 2005 | 270 | 0.080 |
Why?
|
Administration, Oral | 2 | 2012 | 4014 | 0.080 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3821 | 0.080 |
Why?
|
Inflammation | 3 | 2022 | 10758 | 0.080 |
Why?
|
Borrelia burgdorferi | 1 | 2010 | 183 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36418 | 0.080 |
Why?
|
Pain | 2 | 2021 | 5070 | 0.070 |
Why?
|
Aspirin | 5 | 2007 | 3128 | 0.070 |
Why?
|
Drug Administration Schedule | 3 | 2011 | 4849 | 0.070 |
Why?
|
Data Collection | 1 | 2016 | 3319 | 0.070 |
Why?
|
Rheumatic Fever | 1 | 2007 | 73 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3754 | 0.070 |
Why?
|
Minocycline | 1 | 2008 | 169 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1897 | 0.070 |
Why?
|
Early Diagnosis | 1 | 2011 | 1187 | 0.070 |
Why?
|
Disease Management | 3 | 2021 | 2508 | 0.070 |
Why?
|
Muscle Weakness | 1 | 2009 | 412 | 0.070 |
Why?
|
Prognosis | 7 | 2021 | 29672 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4340 | 0.060 |
Why?
|
Age Factors | 4 | 2019 | 18385 | 0.060 |
Why?
|
Double-Blind Method | 4 | 2014 | 12341 | 0.060 |
Why?
|
Age of Onset | 4 | 2024 | 3307 | 0.060 |
Why?
|
Europe | 1 | 2012 | 3422 | 0.060 |
Why?
|
Antibodies | 2 | 2023 | 2415 | 0.060 |
Why?
|
Risk Assessment | 5 | 2020 | 24013 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1255 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2855 | 0.060 |
Why?
|
Autoimmunity | 2 | 2008 | 1354 | 0.060 |
Why?
|
Infant, Newborn | 7 | 2016 | 26187 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2010 | 1436 | 0.060 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2005 | 386 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10203 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2011 | 14607 | 0.060 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6504 | 0.060 |
Why?
|
Immunoglobulins | 1 | 2007 | 851 | 0.060 |
Why?
|
Antibodies, Bacterial | 2 | 2020 | 1463 | 0.060 |
Why?
|
Injections, Intravenous | 2 | 1998 | 1376 | 0.060 |
Why?
|
Patient Discharge | 1 | 2016 | 3441 | 0.050 |
Why?
|
Coronary Disease | 2 | 1999 | 5921 | 0.050 |
Why?
|
Reference Values | 3 | 2019 | 4922 | 0.050 |
Why?
|
Bronchitis | 1 | 2003 | 196 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 185 | 0.050 |
Why?
|
Incidence | 2 | 2023 | 21357 | 0.050 |
Why?
|
Scleroderma, Systemic | 1 | 2006 | 344 | 0.050 |
Why?
|
Follow-Up Studies | 5 | 2011 | 39121 | 0.050 |
Why?
|
Glycosylation | 2 | 2018 | 1095 | 0.050 |
Why?
|
Proteomics | 3 | 2023 | 3836 | 0.050 |
Why?
|
Mixed Connective Tissue Disease | 1 | 2002 | 32 | 0.050 |
Why?
|
Plasmapheresis | 1 | 2002 | 207 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 606 | 0.050 |
Why?
|
Time Factors | 7 | 2014 | 39953 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2019 | 1852 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4744 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2024 | 713 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2005 | 1154 | 0.050 |
Why?
|
Microscopic Polyangiitis | 1 | 2021 | 46 | 0.050 |
Why?
|
Insect Repellents | 1 | 2020 | 17 | 0.050 |
Why?
|
Acute Kidney Injury | 1 | 1993 | 1923 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7873 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10755 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2021 | 22157 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2002 | 445 | 0.050 |
Why?
|
Sensation Disorders | 1 | 2002 | 158 | 0.050 |
Why?
|
Churg-Strauss Syndrome | 1 | 2021 | 75 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2003 | 13630 | 0.040 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.040 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 255 | 0.040 |
Why?
|
International Cooperation | 1 | 2006 | 1423 | 0.040 |
Why?
|
Odds Ratio | 1 | 2012 | 9648 | 0.040 |
Why?
|
Chronic Disease | 2 | 2012 | 9317 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 135 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15308 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1250 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 885 | 0.040 |
Why?
|
Risk Factors | 7 | 2023 | 74219 | 0.040 |
Why?
|
Prospective Studies | 4 | 2019 | 54419 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4574 | 0.040 |
Why?
|
Parvoviridae Infections | 1 | 1998 | 36 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 1998 | 40 | 0.040 |
Why?
|
Borrelia burgdorferi Group | 1 | 1998 | 97 | 0.040 |
Why?
|
Serologic Tests | 1 | 2020 | 381 | 0.040 |
Why?
|
Analgesia, Epidural | 1 | 2002 | 332 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
Fathers | 1 | 2001 | 375 | 0.040 |
Why?
|
Syndrome | 2 | 2002 | 3269 | 0.040 |
Why?
|
Hepatitis, Viral, Human | 1 | 1998 | 141 | 0.040 |
Why?
|
Cohort Studies | 5 | 2014 | 41486 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2019 | 250 | 0.040 |
Why?
|
Movement Disorders | 1 | 2002 | 459 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 913 | 0.040 |
Why?
|
Young Adult | 5 | 2016 | 59199 | 0.040 |
Why?
|
Coronary Vessel Anomalies | 1 | 2020 | 307 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 976 | 0.040 |
Why?
|
Boston | 2 | 2021 | 9324 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 597 | 0.030 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2020 | 866 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1867 | 0.030 |
Why?
|
Central Nervous System | 1 | 2024 | 1333 | 0.030 |
Why?
|
Exanthema | 1 | 2001 | 503 | 0.030 |
Why?
|
Cytokines | 2 | 2023 | 7386 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1042 | 0.030 |
Why?
|
Databases, Factual | 2 | 2014 | 7969 | 0.030 |
Why?
|
Sex Distribution | 2 | 2014 | 2278 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2002 | 1264 | 0.030 |
Why?
|
Point Mutation | 1 | 2001 | 1593 | 0.030 |
Why?
|
Biological Therapy | 1 | 2017 | 139 | 0.030 |
Why?
|
Antibodies, Antinuclear | 2 | 2008 | 342 | 0.030 |
Why?
|
Education | 1 | 1999 | 535 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2001 | 537 | 0.030 |
Why?
|
Age Distribution | 2 | 2014 | 2873 | 0.030 |
Why?
|
Ticlopidine | 1 | 2000 | 730 | 0.030 |
Why?
|
Antigens, CD | 2 | 2007 | 4008 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15845 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1176 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1999 | 793 | 0.030 |
Why?
|
California | 1 | 2019 | 1431 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2001 | 735 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2001 | 1432 | 0.030 |
Why?
|
Disease Progression | 4 | 2019 | 13506 | 0.030 |
Why?
|
Sinusitis | 1 | 2003 | 991 | 0.030 |
Why?
|
Complement C1 Inactivator Proteins | 1 | 1994 | 89 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2009 | 4947 | 0.030 |
Why?
|
Attitude to Health | 1 | 2003 | 2024 | 0.030 |
Why?
|
Skin Diseases | 1 | 2002 | 1095 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2393 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.030 |
Why?
|
Aorta | 1 | 2001 | 2040 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2014 | 377 | 0.030 |
Why?
|
Physical Stimulation | 1 | 2014 | 517 | 0.030 |
Why?
|
Child Behavior | 1 | 1998 | 848 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4109 | 0.030 |
Why?
|
Psoriasis | 1 | 2000 | 945 | 0.020 |
Why?
|
Bone Conduction | 1 | 1992 | 102 | 0.020 |
Why?
|
Fibroblasts | 1 | 2002 | 4137 | 0.020 |
Why?
|
Audiometry, Pure-Tone | 1 | 1992 | 210 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1725 | 0.020 |
Why?
|
Contractile Proteins | 1 | 2012 | 240 | 0.020 |
Why?
|
Adult | 9 | 2024 | 221083 | 0.020 |
Why?
|
Auditory Threshold | 1 | 1992 | 369 | 0.020 |
Why?
|
Metalloendopeptidases | 1 | 2012 | 389 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2010 | 84 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2007 | 9416 | 0.020 |
Why?
|
Salicylates | 1 | 1991 | 127 | 0.020 |
Why?
|
Pilot Projects | 2 | 2022 | 8639 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3210 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2000 | 2075 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
Skin | 1 | 2024 | 4473 | 0.020 |
Why?
|
Hearing Tests | 1 | 1990 | 121 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 1998 | 918 | 0.020 |
Why?
|
Health Status | 1 | 2003 | 4077 | 0.020 |
Why?
|
Drug Resistance | 1 | 1996 | 1594 | 0.020 |
Why?
|
Sex Factors | 2 | 2014 | 10552 | 0.020 |
Why?
|
Forecasting | 1 | 1999 | 2928 | 0.020 |
Why?
|
Blood Cell Count | 1 | 1990 | 396 | 0.020 |
Why?
|
Body Surface Area | 2 | 2001 | 197 | 0.020 |
Why?
|
Acute Disease | 4 | 2007 | 7240 | 0.020 |
Why?
|
Retreatment | 1 | 2010 | 598 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4372 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1803 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2000 | 2746 | 0.020 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2008 | 71 | 0.020 |
Why?
|
Serum Albumin | 1 | 1991 | 674 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1597 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7189 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2008 | 426 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2012 | 1129 | 0.020 |
Why?
|
Pulse Therapy, Drug | 1 | 2007 | 37 | 0.020 |
Why?
|
Treatment Failure | 1 | 1993 | 2643 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4386 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2014 | 1834 | 0.020 |
Why?
|
Chorea | 1 | 2007 | 79 | 0.020 |
Why?
|
Recurrence | 1 | 1998 | 8456 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13254 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2012 | 2189 | 0.020 |
Why?
|
Databases as Topic | 1 | 2007 | 473 | 0.020 |
Why?
|
Electrocardiography | 1 | 1998 | 6385 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10213 | 0.020 |
Why?
|
Algorithms | 2 | 2019 | 14023 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14676 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1993 | 1796 | 0.010 |
Why?
|
Receptors, IgE | 1 | 2005 | 375 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3801 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2005 | 17889 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2545 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168083 | 0.010 |
Why?
|
Quality of Life | 1 | 2024 | 13362 | 0.010 |
Why?
|
Seasons | 1 | 2007 | 1517 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1995 | 3535 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20120 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3803 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1603 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18926 | 0.010 |
Why?
|
Social Adjustment | 1 | 2003 | 632 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3268 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2009 | 1860 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2006 | 2706 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2005 | 1505 | 0.010 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 1998 | 28 | 0.010 |
Why?
|
Dermatitis, Atopic | 1 | 2005 | 731 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
Benchmarking | 1 | 2003 | 1045 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3367 | 0.010 |
Why?
|
Insurance, Health | 1 | 2007 | 2494 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26068 | 0.010 |
Why?
|
Family | 1 | 2005 | 3193 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2012 | 22129 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2007 | 12058 | 0.010 |
Why?
|
Neutrophils | 1 | 2007 | 3763 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 30006 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2007 | 5296 | 0.010 |
Why?
|
Orthopedic Procedures | 1 | 2003 | 1276 | 0.010 |
Why?
|
Angioedema | 1 | 1994 | 184 | 0.010 |
Why?
|
Survival Rate | 1 | 2006 | 12727 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2632 | 0.010 |
Why?
|
Ultrafiltration | 1 | 1991 | 48 | 0.010 |
Why?
|
Macrophages | 1 | 2005 | 5754 | 0.010 |
Why?
|
Autoantigens | 1 | 1994 | 887 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1991 | 561 | 0.010 |
Why?
|
Phenotype | 1 | 2006 | 16572 | 0.000 |
Why?
|
Comorbidity | 1 | 2003 | 10514 | 0.000 |
Why?
|
Aging | 1 | 2007 | 8701 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2503 | 0.000 |
Why?
|
Mice | 1 | 2012 | 81324 | 0.000 |
Why?
|
Ultrasonography | 1 | 1998 | 5971 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13404 | 0.000 |
Why?
|
Peptides | 1 | 1994 | 4353 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 17598 | 0.000 |
Why?
|
Protein Binding | 1 | 1991 | 9300 | 0.000 |
Why?
|
Middle Aged | 1 | 2006 | 220835 | 0.000 |
Why?
|